Arbutus Biopharma Corp - Form 4 Filing

Robert A. Beardsley, a director at Arbutus Biopharma Corp, reported a disposition of 17,948 common shares on October 1, 2026. These shares were tendered to the company pursuant to a tender offer, and the transaction was completed on the same date. The sale price was $5.00 per share, resulting in 14,328 shares remaining in Beardsley's ownership post-transaction. The filing, designated as Form 4, was signed on October 7, 2026, by Tuan Nguyen as attorney-in-fact for Beardsley.